Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Growth of foreign cells after conditional and selective destruction of fetal host cells

a technology of host cells and foreign cells, applied in the field of chimeric mammals, can solve the problems of difficult expansion of differentiated cells, limited success in cells in vitro, and ineffective cost-effectiveness of stem cell differentiation in vitro, and achieve the effect of enhancing the growth of foreign cells

Inactive Publication Date: 2010-03-25
XIMEREX
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Efforts to produce cells in vitro have met with limited success.
While embryonic stem cells can be expanded indefinitely, it is difficult to expand differentiated cells.
Moreover, it is currently not cost-effective to produce differentiated cells from stem cells in vitro.
Two factors make it challenging to grow foreign cells in animals, however.
Second, the foreign cells would need to compete with the native cells of the animal.
However, the human lymphocytes are not appropriately functional and do not provide a normal immune response (2, 3).
The native hepatocytes in these mice were defective and did not survive long.
This model is not practical, however.
Mice cannot be used as a source of donor organs.
Due to the death of the mouse hepatocytes, the homozygous mice are difficult to keep alive.
The mice often die of liver failure before the human hepatocytes provide support.
Because they lack a functional immune system, however this model has limited value for the development of vaccines.
But while engraftment was enhanced, overall survival was not generally improved.
Following hepatic necrosis, most mice did not survive long enough to allow the differentiation and organization of the new hepatocytes.
The small size of the mouse also limits the application of this system, because chimeric livers could not be produced for human transplantation.
Foreign cells have been infused into fetal animals, leading to limited engraftment.
However, engraftment of foreign cells is very limited due to competition with the native host cells.
While transgenic mice can be readily produced to study diseases related to a specific gene, it is not practical to produce large animals.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Growth of foreign cells after conditional and selective destruction of fetal host cells
  • Growth of foreign cells after conditional and selective destruction of fetal host cells
  • Growth of foreign cells after conditional and selective destruction of fetal host cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

Growth of Human Hepatocytes in Fetal Pigs

[0098]These studies demonstrate that human hepatocytes survive in fetal pigs and produce human liver proteins.

[0099]Pig livers can provide temporary support for patients with acute liver failure. Because many proteins produced by the liver are species specific, however, these xenografts might not be adequate for long-term support. To produce chimeric pig livers repopulated in part with human hepatocytes, fetal pigs were infused with human hepatocytes.

[0100]Human hepatocytes were injected into the livers of pre-immune fetal pigs (45 days gestation) using ultrasound guidance. Frozen and thawed human hepatocytes were infused into 8 piglets (2 or 5×106 cells) from two litters. The two piglets of another litter were infused with human hepatocytes transformed with SV40 (10×106 cells). After farrowing, a fourth litter was euthanized at 5 days and the tissues analyzed. Piglets of the first three litters were followed by testing their sera for human l...

example 2

Growth of Human Hepatocytes from Marrow or Cord Blood Cells in Fetal Pigs

[0104]This example demonstrates that both human bone marrow and cord blood are appropriate sources for hepatocytes.

[0105]Hematopoetic stem cells demonstrate plasticity, with the ability to differentiate into somatic cells. In this study, human marrow or cord blood cells were infused into fetal pigs. The resulting chimeric pigs were assessed for evidence of human hepatocytes and serum proteins secreted by the human hepatocytes.

[0106]Human marrow cells (1.5 to 3×107 / pig) or cord blood cells (1−1.5×107 / pig) were injected into the livers of pre-immune fetal pigs (45 days gestation) using ultrasound guidance. The marrow was depleted of 75% of the CD4+ and CD8+T cells. The pigs were delivered by Cesarean section at term. At 1 to 2 weeks of age, serum was evaluated for human serum amyloid A (hSAA) and human albumin (hAlb) using an ELISA. Paraffin-embedded sections of liver were stained by immunoperoxidase for human al...

example 3

Expression of a Suicide Gene Product in a Cell Line and Sensitivity to a Prodrug

[0108]This example shows that selective expression of a suicide gene product and selective killing of target cells can be controlled by a tissue-specific promoter.

[0109]Liver cell lines were transfected with suicide genes controlled by either an albumin or an α-fetoprotein promoter. Albumin and α-fetoprotein are expressed primarily in hepatocytes, with α-fetoprotein expressed more in immature hepatocytes and liver carcinoma lines.

[0110]Mouse and human liver cell lines were transfected with constructs containing delta thymidine kinase under the control of either a porcine albumin or α-fetoprotein (AFP) promoter. The mouse cell line (TIB73) is a line of mature hepatocytes in which albumin is expressed. The human cell line (Huh-7) is a line of hepatocellular carcinoma cells that express predominantly AFP. The transfected cells were tested for thymidine kinase by Western blot.

[0111]To assess the function of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Foreign cells can be grown in fetal non-mammalian hosts for the production of transplant organs and tissues, the development of new therapeutic agents, and the production of biological factors and drugs. Tissue-specific injury to fetal host target cells is carried without substantial injury to the maternal host or foreign cells, providing an environment in which the injured tissue can be regenerated with the foreign cells.

Description

[0001]This application is a continuation of pending U.S. Ser. No. 10 / 527,587, filed Feb. 21, 2006, which is a national stage application of PCT application PCT / US2003 / 02951, filed Sep. 17, 2003, which claims the benefit of provisional application Ser. No. 60 / 411,790, filed Sep. 19, 2002. These applications are incorporated herein in their entireties.[0002]This application incorporates by reference the contents of a 12 kb text file created on Nov. 2, 2009 and named “000241—00013_Seq_List.txt,” which is the sequence listing for this application.[0003]This invention was made with government funds from ATP grant no. 70NANB0H3008 from NIST, Department of Commerce. The government retains certain rights in the invention.FIELD OF THE INVENTION[0004]The invention relates to the growth and differentiation of foreign cells within a mammalian host. In particular, the invention relates to chimeric mammals that can be used to develop new drugs and vaccines, as well as to produce factors, drugs, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/07A01K67/027C12N5/00C12N5/06
CPCA01K67/0271A01K67/0275A01K2217/05A01K2217/30C12N2510/00A01K2267/025A61K9/127C12N5/0081A01K2227/108
Inventor BESCHORNER, WILLIAM E.SOSA, CARLOS E.THOMPSON, SCOTT C.
Owner XIMEREX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com